Angioplasty.Org
Most Popular Angioplasty Web Site
   
supported by Volcano Corporation
78% Increase in Intravascular Ultrasound Systems Sales Boosts Volcano Quarterly Growth by 40%

external sites:
Volcano Corporation

November 5, 2008. San Diego -- Volcano Corporation (Nasdaq: VOLC), a leader in the development, manufacturing and sales of products for the diagnosis and treatment of coronary and peripheral artery disease, today reported that revenues for the third quarter of 2008 increased 40 percent over those in the third quarter of 2007.

For the quarter ended September 30, 2008, Volcano reported revenues of $44.1 million versus revenues of $31.5 million in the same period a year ago. The company said that its financial performance was driven by a 78 percent increase in intravascular ultrasound (IVUS) system revenues and a 29 percent increase in IVUS disposable revenues year-over-year.

For the third quarter of 2008, the company reported net income on a GAAP basis of $744,000, or $0.01 per diluted share, versus a net loss on a GAAP basis of $652,000 or $0.02 per share, in the third quarter of 2007. Weighted average shares at the end of the quarter were 50.3 million versus 38.7 million a year ago, reflecting the impact of the company's equity offering that was completed in the fourth quarter of 2007.

Excluding stock-based compensation expense of $2.5 million, the company reported net income of $3.3 million, or $0.06 per diluted share. In the third quarter of 2007, excluding stock-based compensation expense of $2.0 million, the company reported net income of $1.3 million, or $0.03 per diluted share. A reconciliation of the company's GAAP and non-GAAP results can be found in today's earnings news release on the company's website at http://www.volcanocorp.com.

For the first nine months of 2008, Volcano reported revenues of $122.2 million, a 35 percent increase over revenues of $90.6 million in the same period a year ago. On a GAAP basis, the company reported a net loss of $15.1 million, or $0.32 per share, compared with a net loss of $2.8 million, or $0.07 per share, in the same period a year ago. Excluding in-process research and development charges of $12.4 million, $2.9 million in due diligence, legal and accounting expenses related to a proposed acquisition that was not consummated, and stock-based compensation expense of $7.0 million, Volcano reported net income of $7.2 million, or $0.14 per diluted share, in the first nine months of 2008. Excluding stock-based compensation expense of $4.7 million, the company reported net income of $1.9 million, or $0.04 per diluted share, in the first nine months of 2007.

"We continue to gain market share across all of our businesses and geographies, while realizing gross margin improvement and leveraging our operating expenses. As a result, we achieved profitability on a GAAP basis in the third quarter of 2008, and have raised our outlook for earnings per share for the full year," said Scott Huennekens, president and chief executive officer.

"Through the first nine months of 2008, we have placed 537 of our IVUS consoles versus 420 in the first nine months a year ago, and now have more than 3,700 of our IVUS and Functional Measurement (FM) consoles placed worldwide. Helping to drive our growth is the leading-edge technology offered by our devices and Volcano's strong sales and market development initiatives. In addition, we are seeing an increasingly favorable environment for percutaneous coronary interventions and an ongoing flow of positive data, including that presented in a number of presentations at the recent Transcatheter Cardiovascular Therapeutics (TCT) meeting," Huennekens noted.

"At the same time," he added, "we continue to be excited about our new product pipeline that will enable us to address markets that are potentially larger than those we are currently serving."

Guidance for 2008
The company updated its guidance for fiscal 2008. It now expects that revenues will be at the upper end of its previous range of $164-$168 million, which represents an increase of approximately 27 to 29 percent over full year revenues in 2007. It now expects gross margin to be in the range of 62-63 percent versus prior guidance of 60-61 percent. The company reiterated that it expects operating expenses, including stock-based compensation, due diligence costs recorded in the first quarter, the in-process research and development costs of $12.4 million incurred in the first half of the year, ongoing expenses associated with the development of technology acquired through the Novelis transaction and approximately $3.1 million of intangible amortization, will be 74-76 percent of revenues. For the full year 2008, the company expects that on a GAAP basis it will record a net loss of $0.30-$0.32 per share versus prior guidance of $0.33-$0.37 per share. The company expects to be profitable on a GAAP basis in the fourth quarter of 2008. Excluding stock-based compensation expense of approximately $10.0 million, due diligence and in- process research and development costs, the company expects to report non-GAAP net income of $0.18-$0.20 per diluted share. This compares with prior guidance for non-GAAP net income of $0.14-$0.18 per share. Weighted average shares outstanding at year-end 2008 are expected to be approximately 47.4 million basic shares and 50.4 million shares on a diluted basis.

Conference Call
The company will hold a conference call at 2 p.m., Pacific Standard Time (5 p.m. Eastern Standard Time) today. The teleconference can be accessed by calling (719) 325-4761, passcode 8632414, or via the company's website at http://www.volcanocorp.com. Please dial in or access the webcast 10-15 minutes prior to the beginning of the call. A replay of the conference call will be available through November 12 at (719) 457-0820, passcode 8632414, and via the company's website.

Volcano Corporation
Volcano Corporation (Nasdaq: VOLC) offers a broad suite of devices designed to facilitate endovascular procedures, enhance the diagnosis of vascular and structural heart disease and guide optimal therapies. The company's intravascular ultrasound (IVUS) product line includes ultrasound consoles that can be integrated directly into virtually any modern cath lab. Volcano IVUS offers unique features, including both single-use phased array and rotational IVUS imaging catheters, and advanced functionality options, such as VH(TM) tissue characterization and ChromaFlo(R). Volcano also provides functional measurement (FM) consoles and single-use pressure and flow guide wires and is developing a line of ultra-high resolution Optical Coherence Tomography (OCT) systems and catheters. Currently, more than 3,700 Volcano IVUS and FM systems are installed worldwide, with approximately half of its revenues coming from outside the United States. For more information, visit the company's website at http://www.volcanocorp.com.

Use of Non-GAAP Financial Measures
This press release includes certain non-GAAP financial information as defined by the U.S. Securities and Exchange Commission Regulation G. Pursuant to the requirements of this regulation, a reconciliation of this non-GAAP financial information to our financial statements as prepared under generally accepted accounting principles in the United States (GAAP) is included in this press release. Non-GAAP financial measures provide an indication of our performance before certain charges. Our management believes that in order to properly understand our short-term and long-term financial trends, investors may wish to consider the impact of these charges. These charges result from facts and circumstances that vary in frequency and/or impact on continuing operations. Our management believes that these items should be excluded when comparing our current operating results with those of prior periods as stock- based compensation is a non-cash expense, in-process research and development relates to the costs associated with the May 2008 acquisition of Novelis, Inc., and the December 2007 acquisition of CardioSpectra, Inc., and the acquisition due diligence costs incurred in the first quarter of 2008 related to a proposed acquisition that was not consummated, are not reflective of our core operating activities. In addition, our management uses results of operations before certain charges to evaluate the operational performance of the company and as a basis for strategic planning. Investors should note that the non-GAAP financial measures used by the company may not be the same non- GAAP financial measures, and may not be calculated in the same manner, as those of other companies. Investors should consider these non-GAAP measures in addition to, and not as a substitute for, financial performance measures in accordance with GAAP.

Forward-Looking Statements
This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. Any statements in this release regarding Volcano's business that are not historical facts may be considered "forward-looking statements," including statements regarding the company's financial guidance for 2008, market adoption of the company's technology, the impact of clinical and other technical data, the success and timing of product development and clinical trial programs, growth strategies and market development and product sales. Forward-looking statements are based on management's current preliminary expectations and are subject to risks and uncertainties, which may cause Volcano's results to differ materially and adversely from the statements contained here. Some of the potential risks and uncertainties that could cause actual results to differ from the results predicted are detailed in the company's annual report on Form 10-K, quarterly reports on Form 10-Q and other filings made with the Securities and Exchange Commission. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made. Volcano undertakes no obligation to update any forward-looking statements to reflect new information, events or circumstances after the date they are made, or to reflect the occurrence of unanticipated events.



                               VOLCANO CORPORATION
                      CONDENSED CONSOLIDATED BALANCE SHEETS
                                 (in thousands)
                                   (Unaudited)

                                                September 30,     December 31,
                                                    2008              2007
     Assets
     Current assets:
       Cash and cash equivalents                  $108,662          $122,913
       Short-term available-for-sale
        investments                                 68,049            66,205
       Accounts receivable, net                     25,036            27,976
       Inventories, net                             25,698            21,243
       Prepaid expenses and other current
        assets                                       4,965             3,997
         Total current assets                      232,410           242,334
     Restricted cash                                   360               365
     Property and equipment, net                    19,900            13,692
     Intangible assets, net                          7,439             9,385
     Other non-current assets                          886               798
                                                  $260,995          $266,574

     Liabilities and Stockholders' Equity
     Current liabilities:
       Accounts payable                            $13,139           $11,077
       Accrued compensation                          9,502             9,083
       Accrued expenses and other current
        liabilities                                  7,441             6,600
       Deferred revenues                             4,419             5,360
       Current maturities of long-term debt             58               120
         Total current liabilities                  34,559            32,240
     Long-term debt                                     49                78
     Deferred license fee                              938             1,125
     Other                                             142               194
         Total liabilities                          35,688            33,637
     Stockholders' equity                          225,307           232,937
                                                  $260,995          $266,574



                               VOLCANO CORPORATION
                      CONSOLIDATED STATEMENTS OF OPERATIONS
                      (in thousands, except per share data)
                                   (Unaudited)

                                         Three Months Ended  Nine Months Ended
                                            September 30,      September 30,
                                           2008     2007      2008     2007

    Revenues                              $44,118  $31,474  $122,242  $90,605
    Cost of revenues                       16,581   12,285    45,915   35,466
        Gross profit                       27,537   19,189    76,327   55,139
    Operating expenses:
      Selling, general and administrative  19,546   16,005    62,405   44,271
      Research and development              6,879    4,837    18,823   15,241
      In-process research and development       -        -    12,407        -
      Amortization of intangibles             786      751     2,337    2,313
        Total operating expenses           27,211   21,593    95,972   61,825
    Operating income (loss)                   326   (2,404)  (19,645)  (6,686)
      Interest income                       1,109    1,213     4,206    3,630
      Interest expense                         (2)     (32)       (8)    (193)
      Exchange rate gain (loss)              (441)     829     1,091    1,042
      Income (loss) before provision for
       income taxes                           992     (394)  (14,356)  (2,207)
      Provision for income taxes              248      258       707      626
    Net income (loss)                        $744    $(652) $(15,063) $(2,833)
    Net income (loss) per share - basic     $0.02   $(0.02)   $(0.32)  $(0.07)
    Net income (loss) per share -
     diluted                                $0.01   $(0.02)   $(0.32)  $(0.07)
    Weighted-average shares outstanding
     - basic                               47,456   38,694    47,236   38,368
    Weighted-average shares outstanding
     - diluted                             50,323   38,694    47,236   38,368



                              VOLCANO CORPORATION
             RECONCILIATION OF GAAP AND NON-GAAP OPERATING RESULTS
                     (in thousands, except per share data)
                                  (Unaudited)

                                         Three Months Ended September 30, 2008
                                                      Stock-based
                                              GAAP    compensation  Non-GAAP
                                             results     expense    results

    Revenues                                 $44,118         $-     $44,118
    Cost of revenues                          16,581       (222)     16,359
    Gross profit                              27,537        222      27,759
    Operating expenses:
      Selling, general and administrative     19,546     (1,798)     17,748
      Research and development                 6,879       (493)      6,386
      Amortization of intangibles                786          -         786
        Total operating expenses              27,211     (2,291)     24,920
    Operating income                             326      2,513       2,839
      Interest income                          1,109          -       1,109
      Interest expense                            (2)         -          (2)
      Exchange rate loss                        (441)         -        (441)
        Income before provision for income
         taxes                                   992      2,513       3,505
      Provision for income taxes                 248          -         248
    Net income                                  $744     $2,513      $3,257
    Net income per share - basic               $0.02      $0.05       $0.07
    Net income per share - diluted             $0.01      $0.05       $0.06
    Weighted-average shares outstanding
     - basic                                  47,456                 47,456
    Weighted-average shares outstanding
     - diluted                                50,323                 50,323


                                         Three Months Ended September 30, 2007
                                                      Stock-based
                                              GAAP    compensation  Non-GAAP
                                             results     expense    results

    Revenues                                 $31,474         $-     $31,474
    Cost of revenues                          12,285       (181)     12,104
    Gross profit                              19,189        181      19,370
    Operating expenses:
      Selling, general and administrative     16,005     (1,437)     14,568
      Research and development                 4,837       (359)      4,478
      Amortization of intangibles                751          -         751
        Total operating expenses              21,593     (1,796)     19,797
    Operating loss                            (2,404)     1,977        (427)
      Interest income                          1,213          -       1,213
      Interest expense                           (32)         -         (32)
      Exchange rate gain                         829          -         829
        Income (loss) before provision for
         income taxes                           (394)     1,977       1,583
      Provision for income taxes                 258          -         258
    Net income (loss)                          $(652)    $1,977      $1,325
    Net income (loss) per share - basic       $(0.02)     $0.05       $0.03
    Net income (loss) per share -
     diluted                                  $(0.02)     $0.05       $0.03
    Weighted-average shares outstanding
     - basic                                  38,694                 38,694
    Weighted-average shares outstanding
     - diluted                                38,694                 41,710



                               VOLCANO CORPORATION
              RECONCILIATION OF GAAP AND NON-GAAP OPERATING RESULTS
                      (in thousands, except per share data)
                                   (Unaudited)

                                     Nine Months Ended September 30, 2008

                                           Stock-     In-
                                           based    process  Acquisition
                                         compensa-  research     due     Non-
                                  GAAP     tion       and     diligence  GAAP
                                results   expense development   costs  results

    Revenues                   $122,242       $-        $-       $-  $122,242
    Cost of revenues             45,915     (598)        -        -    45,317
    Gross profit                 76,327      598         -        -    76,925
    Operating expenses:
      Selling, general and
       administrative            62,405   (5,094)        -   (2,878)   54,433
      Research and development   18,823   (1,305)        -        -    17,518
      In-process research and
       development               12,407        -   (12,407)       -         -
      Amortization of
       intangibles                2,337        -         -        -     2,337
        Total operating
         expenses                95,972   (6,399)  (12,407)  (2,878)   74,288
    Operating income (loss)     (19,645)   6,997    12,407    2,878     2,637
      Interest income             4,206        -         -        -     4,206
      Interest expense               (8)       -         -        -        (8)
      Exchange rate gain          1,091        -         -        -     1,091
        Income (loss) before
         provision for income
         taxes                  (14,356)   6,997    12,407    2,878     7,926
      Provision for income taxes    707        -         -        -       707
    Net income (loss)          $(15,063)  $6,997   $12,407   $2,878    $7,219
    Net income (loss) per share
     - basic                     $(0.32)   $0.15     $0.26    $0.06     $0.15
    Net income (loss) per share
     - diluted                   $(0.32)   $0.14     $0.25    $0.06     $0.14
    Weighted-average shares
     outstanding - basic         47,236                                47,236
    Weighted-average shares
     outstanding - diluted       47,236                                49,859


                                     Nine Months Ended September 30, 2007
                                           Stock-     In-
                                           based    process  Acquisition
                                         compensa-  research     due     Non-
                                  GAAP     tion       and     diligence  GAAP
                                results   expense development   costs  results

    Revenues                    $90,605       $-        $-       $-   $90,605
    Cost of revenues             35,466     (434)        -        -    35,032
    Gross profit                 55,139      434         -        -    55,573
    Operating expenses:
      Selling, general and
       administrative            44,271   (3,486)        -        -    40,785
      Research and development   15,241     (783)        -        -    14,458
      Amortization of
       intangibles                2,313        -         -        -     2,313
        Total operating
         expenses                61,825   (4,269)        -        -    57,556
    Operating loss               (6,686)   4,703         -        -    (1,983)
      Interest income             3,630        -         -        -     3,630
      Interest expense             (193)       -         -        -      (193)
      Exchange rate gain          1,042        -         -        -     1,042
        Income (loss) before
         provision for income
         taxes                   (2,207)   4,703         -        -     2,496
      Provision for income taxes    626        -         -        -       626
    Net income (loss)           $(2,833)  $4,703        $-       $-    $1,870
    Net income (loss) per share
     - basic                     $(0.07)   $0.12        $-       $-     $0.05
    Net income (loss) per share
     - diluted                   $(0.07)   $0.11        $-       $-     $0.04
    Weighted-average shares
     outstanding - basic         38,368                                38,368
    Weighted-average shares
     outstanding - diluted       38,368                                41,739


Use of Non-GAAP Financial Measures
This press release includes certain non-GAAP financial information as defined by the U.S. Securities and Exchange Commission Regulation G. Pursuant to the requirements of this regulation, a reconciliation of this non-GAAP financial information to our financial statements as prepared under generally accepted accounting principles in the United States (GAAP) is included in this press release. Non-GAAP financial measures provide an indication of our performance before certain charges. Our management believes that in order to properly understand our short-term and long-term financial trends, investors may wish to consider the impact of these charges. These charges result from facts and circumstances that vary in frequency and/or impact on continuing operations. Our management believes that these items should be excluded when comparing our current operating results with those of prior periods as stock- based compensation is a non-cash expense, in-process research and development relates to the costs associated with the May 2008 acquisition of Novelis, Inc. and the December 2007 acquisition of CardioSpectra, Inc., and the acquisition due diligence costs incurred in the first quarter of 2008 related to a proposed acquisition that was not consummated, are not reflective of our core operating activities. In addition, our management uses results of operations before certain charges to evaluate the operational performance of the company and as a basis for strategic planning. Investors should note that the non-GAAP financial measures used by the company may not be the same non-GAAP financial measures, and may not be calculated in the same manner, as those of other companies. Investors should consider these non-GAAP measures in addition to, and not as a substitute for, financial performance measures in accordance with GAAP.


                               VOLCANO CORPORATION
                                 REVENUE SUMMARY
                                  (in millions)
                                   (Unaudited)


                                                  Growth  YTD Q3 YTD Q3
                                   Q3 '08  Q3 '07    %      '08    '07  Growth
    IVUS Systems:
      United States                 $5.6    $3.4    62%   $15.3  $11.0    40%
      Japan                          2.5     0.5   376%     4.9    1.8   172%
      Europe                         1.8     1.5    24%     5.4    3.5    50%
      Rest of World                  0.7     0.5    38%     1.9    1.7    14%
    Total IVUS Systems             $10.6    $5.9    78%   $27.5  $18.0    52%

    IVUS Disposables:
      United States                $13.0   $10.1    30%   $37.6  $28.8    31%
      Japan                          8.9     7.5    18%    24.7   20.3   22%
      Europe                         4.6     3.0    51%    13.0    9.0    44%
      Rest of World                  0.7     0.5    27%     2.2    1.6    35%
    Total IVUS Disposables         $27.2   $21.1    29%   $77.5  $59.7    30%

    FM:
      United States                 $2.3    $1.4    63%    $6.3   $4.5    40%
      Japan                          0.5     0.2   186%     0.9    1.1   -16%
      Europe                         1.7     1.5    19%     5.1    4.1    24%
      Rest of World                  0.4     0.2    94%     0.8    0.6    43%
    Total FM                        $4.9    $3.3    51%   $13.1  $10.3    28%

    Other                            1.4     1.2    25%     4.1    2.6    56%
        Total                      $44.1   $31.5    40%  $122.2  $90.6    35%

Source: Volcano Corporation